Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Taira, Y.
Right arrow Articles by Sakabe, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taira, Y.
Right arrow Articles by Sakabe, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2000, Vol. 85, No. 6 881-886
© 2000 The Board of Management and Trustees of the British Journal of Anaesthesia

Spinal and supraspinal midazolam potentiates antinociceptive effects of isoflurane

Y. Taira1, K. Nakakimura, M. Matsumoto and T. Sakabe

Department of Anesthesiology-Resuscitology, Yamaguchi University School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan 1Present address: Department of Anesthesia, Aso-Yamanami Hospital, 115-1 Miyaji, Itinomiya-cho, Aso-gun, Kumamoto 869-2612, Japan*Corresponding author

The effects of lumbar intrathecal (i.t.) and intracerebroventricular (i.c.v.) midazolam on nociception during isoflurane anaesthesia were studied in rats using the tail-flick test. Rats received i.t. midazolam 2 and 4 µg or i.c.v. midazolam 4 and 8 µg during 1.1, 1.2 and 1.3% isoflurane or without isoflurane. Neither i.t. nor i.c.v. midazolam alone at doses studied influenced nociceptive responses. 1.1% isoflurane showed a minimum antinociceptive effect which was not influenced by i.t. or i.c.v. midazolam. 1.2 and 1.3% isoflurane produced moderate antinociception which was markedly potentiated by both i.t. and i.c.v. midazolam. The effects of midazolam shown in the present study are different from the reported effects of midazolam on opioid-induced antinociception; where spinally administered midazolam potentiates and supraspinal midazolam inhibits the antinociceptive effects of morphine. The present results suggest that midazolam potentiates isoflurane-induced antinociception at doses where no effect is seen alone.

Br J Anaesth 2000; 85: 881–6


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Canadian J. AnesthesiaHome page
T. Nishiyama
Analgesic effects of systemic midazolam: comparison with intrathecal administration: [Les effets analgesiques du midazolam a action generale : comparaison avec l'administration intrathecale].
Can J Anesth, October 1, 2006; 53(10): 1004 - 1009.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. L. Yaksh and J. W. Allen
The Use of Intrathecal Midazolam in Humans: A Case Study of Process
Anesth. Analg., June 1, 2004; 98(6): 1536 - 1545.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. I Eger II, Y. Xing, M. Laster, J. Sonner, J. F. Antognini, and E. Carstens
Halothane and Isoflurane Have Additive Minimum Alveolar Concentration (MAC) Effects in Rats
Anesth. Analg., May 1, 2003; 96(5): 1350 - 1353.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.